Login / Signup

What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non-pharmacological trials in palliative care.

Lesley DunleavyDanni Collingridge MooreIda KorfageSheila PayneCatherine WalsheNancy Preston
Published in: BMC palliative care (2021)
ACTION trial registration number: ISRCTN63110516 (date of registration 03/10/2014). Namaste trial registration number: ISRCTN14948133 (date of registration 04/10/2017).
Keyphrases
  • palliative care
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • primary care
  • healthcare
  • adverse drug
  • randomized controlled trial
  • quality improvement
  • open label
  • advanced cancer
  • emergency department